Literature DB >> 30167723

[Neuro-otology: at the borders of ear and brain].

A Zwergal1,2, V Kirsch3,4, J Gerb3,4, J Dlugaiczyk4, S Becker-Bense4, M Dieterich3,4.   

Abstract

Vertigo and dizziness are frequent chief complaints in clinical practice. Symptoms may originate from otological, neurological, medical and psychiatric etiologies, which poses an interdisciplinary challenge. Systematic analysis of case history and clinical examination generally allow classification into peripheral-, central- or non-vestibular disorders. The most important criteria for differentiation are the timeline, quality of symptoms, modulating factors and accompanying symptoms. As concerns the clinical examination, the following tests are relevant: head impulse test, test for spontaneous nystagmus, positional nystagmus, central ocular motor signs and the Romberg test. However, neuro-otological disorders with combined peripheral and central vestibular pathology do exist. Occlusion of the anterior inferior cerebellar artery results in ischemia of the labyrinth and cerebellum and therefore causes acute vestibular syndrome and unilateral hearing loss. Repetitive attacks of vertigo or dizziness which are accompanied by ear symptoms and headaches may be due to an overlap syndrome of Menière's disease and vestibular migraine. In this case patients often have to be treated with a dual prophylactic medication to control symptoms. In case of chronic dizziness and instability of gait a subsample of patients may suffer from CANVAS, which is a combination of bilateral vestibulopathy, a cerebellar syndrome and polyneuropathy. Chronic dizziness with signs of peripheral and central vestibular dysfunction can also originate from tumors of the cerebellopontine angle with compression of central structures. In conclusion, the diagnostic algorithm in the workup of patients with vertigo and dizziness should always include tests for peripheral and central vestibular and ocular motor function.

Entities:  

Keywords:  Bilateral vestibulopathy; Brain ischemia; Cerebellar syndromes; Menière’s disease; Vestibular migraine

Mesh:

Year:  2018        PMID: 30167723     DOI: 10.1007/s00115-018-0598-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  33 in total

1.  In vivo visualization of endolyphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function.

Authors:  Robert Gürkov; Wilhem Flatz; Julia Louza; Michael Strupp; Eike Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-23       Impact factor: 2.503

2.  Chasing dizzy chimera: Diagnosis of combined peripheral and central vestibulopathy.

Authors:  Seo-Young Choi; Hyo-Jung Kim; Ji-Soo Kim
Journal:  J Neurol Sci       Date:  2016-10-15       Impact factor: 3.181

3.  Why acute unilateral vestibular cortex lesions mostly manifest without vertigo.

Authors:  Marianne Dieterich; Thomas Brandt
Journal:  Neurology       Date:  2015-03-27       Impact factor: 9.910

4.  Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department.

Authors:  Babak B Navi; Hooman Kamel; Maulik P Shah; Aaron W Grossman; Christine Wong; Sharon N Poisson; William D Whetstone; S Andrew Josephson; S Claiborne Johnston; Anthony S Kim
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

5.  Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome.

Authors:  D J Szmulewicz; J A Waterston; G M Halmagyi; S Mossman; A M Chancellor; C A McLean; E Storey
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

6.  Falls and fear of falling in vertigo and balance disorders: A controlled cross-sectional study.

Authors:  Cornelia Schlick; Roman Schniepp; Verena Loidl; Max Wuehr; Kristin Hesselbarth; Klaus Jahn
Journal:  J Vestib Res       Date:  2016       Impact factor: 2.435

7.  The TriAGe+ Score for Vertigo or Dizziness: A Diagnostic Model for Stroke in the Emergency Department.

Authors:  R Kuroda; T Nakada; T Ojima; M Serizawa; N Imai; N Yagi; A Tasaki; M Aoki; T Oiwa; T Ogane; K Mochizuki; M Kobari; H Miyajima
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-03-01       Impact factor: 2.136

8.  Abnormal thalamic function in patients with vestibular migraine.

Authors:  Antonio Russo; Vincenzo Marcelli; Fabrizio Esposito; Virginia Corvino; Laura Marcuccio; Antonio Giannone; Renata Conforti; Elio Marciano; Gioacchino Tedeschi; Alessandro Tessitore
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

9.  HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging.

Authors:  Jorge C Kattah; Arun V Talkad; David Z Wang; Yu-Hsiang Hsieh; David E Newman-Toker
Journal:  Stroke       Date:  2009-09-17       Impact factor: 7.914

10.  Quantitative video-oculography to help diagnose stroke in acute vertigo and dizziness: toward an ECG for the eyes.

Authors:  David E Newman-Toker; Ali S Saber Tehrani; Georgios Mantokoudis; John H Pula; Cynthia I Guede; Kevin A Kerber; Ari Blitz; Sarah H Ying; Yu-Hsiang Hsieh; Richard E Rothman; Daniel F Hanley; David S Zee; Jorge C Kattah
Journal:  Stroke       Date:  2013-03-05       Impact factor: 7.914

View more
  3 in total

1.  A probabilistic atlas of the human inner ear's bony labyrinth enables reliable atlas-based segmentation of the total fluid space.

Authors:  Valerie Kirsch; F Nejatbakhshesfahani; S-A Ahmadi; M Dieterich; B Ertl-Wagner
Journal:  J Neurol       Date:  2019-08-17       Impact factor: 4.849

Review 2.  Rare Disorders of the Vestibular Labyrinth: of Zebras, Chameleons and Wolves in Sheep's Clothing.

Authors:  Julia Dlugaiczyk
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

3.  Intravenous Delayed Gadolinium-Enhanced MR Imaging of the Endolymphatic Space: A Methodological Comparative Study.

Authors:  Rainer Boegle; Johannes Gerb; Emilie Kierig; Sandra Becker-Bense; Birgit Ertl-Wagner; Marianne Dieterich; Valerie Kirsch
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.